Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

Clinical trial NCT05001880 · RECRUITING

Trial details

NCT number: NCT05001880
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Peritoneal Malignant Mesothelioma

Start date: 2022-03-22
Primary completion: 2027-08-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.